IPO Calendar
Lead Manager
- J P Morgan Chase (490)
- Goldman Sachs (463)
- Morgan Stanley (421)
- Bank of America Merrill Lynch (358)
- Citigroup (222)
- Jefferies (214)
- Credit Suisse (180)
- Barclays (151)
- Cowen and Company (147)
- Deutsche Bank (84)
- Leerink Partners (70)
- Piper Jaffray (70)
- Stifel (65)
- UBS Investment Bank (53)
- Evercore (52)
- RBC Capital (51)
- BMO Capital (49)
- Wells Fargo (47)
- Raymond James (38)
- William Blair (37)
More +
IPO - Pricing (8)
Leerink Partners
| UnderWriters* | |||||||||||
| Date | Company Name | Sector | Price ($) |
Size (M) |
1 | 2 | 3 | Rank | Turnover | Gain | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 12 | Equillium Inc. | Health-Care | 14 | 4 | JEFF | LRNK | 19.6% | 0% | |||
| Jul 20 | Replimune Group | Health-Care | 15 | 6 | BMO | JPM | LRNK | 46.6% | 1.1% | ||
| Jul 18 | Crinetics Pharm | Health-Care | 17 | 6 | JPM | LRNK | PPRJ | 60% | 44.2% | ||
| Jun 21 | Xeris Pharmaceu | Health-Care | 15 | 5 | JEFF | LRNK | RBC | 36.3% | 34.8% | ||
| May 25 | Iterum Therapeu | Health-Care | 13 | 6 | LRNK | RBC | 11.9% | -1.2% | |||
| May 4 | ASLAN Pharmaceu | Health-Care | 7 | 6 | LRNK | PPRJ | 13.6% | -20.2% | |||
| Mar 15 | Arcus Bioscienc | Health-Care | 15 | 8 | CITI | GS | LRNK | 70% | 13.3% | ||
| Jan 26 | Solid Bioscienc | Health-Care | 16 | 7 | GS | JPM | LRNK | 42.3% | 41.4% | ||
*
Lead manager or one of top three managers in an underwriting team.